Evidence map›Paper›PMID 39210349›Full record

ArticleAIDS research and therapy2024

Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.

Pauline Mary Amuge, Denis Ndekezi, Moses Mugerwa, Dickson Bbuye, Diana Antonia Rutebarika, Lubega Kizza, Christine Namugwanya, Angella Baita, Peter James Elyanu, Patricia Nahirya Ntege and 8 more

Erratum issuedAbstract read
In one paragraph

Article in AIDS research and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Pauline Mary AmugeMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda. paulacallista@gmail.com.
Denis NdekeziDepartment of Social Aspect of Health, Medical Research Council, Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Kampala, Uganda.
Moses MugerwaMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Dickson BbuyeMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Diana Antonia RutebarikaDepartment of Research and Clinical Care, Joint Clinical Research Center, Lubowa, Wakiso, Uganda.
Lubega KizzaMedical Department, Makerere Joint AIDS Program-Mulago ISS Clinic, Kampala, Uganda.
Christine NamugwanyaMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Angella BaitaMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Peter James ElyanuMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Patricia Nahirya NtegeMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Dithan KiraggaMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Carol BirungiMedical Department, Makerere Joint AIDS Program-Mulago ISS Clinic, Kampala, Uganda.
Adeodata Rukyalekere KekitiinwaMulago Hospital, Baylor College of Medicine Children's Foundation-Uganda, Block 5, P.O. Box 72052, Kampala, Uganda.
Agnes KiraggaAfrican Population and Health Research Center, Nairobi, Kenya.
Moorine Peninah SekaddeNational Tuberculosis and Leprosy Program, Ministry of Health, Kampala, Uganda.
Nicole-Austin SalazarSchool of Medicine, Johns Hopkins University, Baltimore, USA.
Anna Maria MandalakasGlobal TB Program, Baylor College of Medicine, Houston, USA.
Philippa MusokeDepartment of Paediatrics and Child Health, Makerere University Johns Hopkins University (MUJHU) Care Limited, Kampala, Uganda.

Funding

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) grant programme at the International AIDS Society (IAS) 1211
6 · The paper itself

Abstract

introductionPeople living with HIV (PLHIV) have a 20-fold risk of tuberculosis (TB) disease compared to HIV-negative people. In 2021, the uptake of TB preventive treatment among the children and adolescents living with HIV at the Baylor-Uganda HIV clinic was 45%, which was below the national target of 90%. Minimal evidence documents the enablers and barriers to TB preventive treatment (TPT) initiation and completion among children and adolescents living with HIV(CALHIV). We explored the facilitators and barriers to TPT initiation and completion among CALHIV among adolescents aged 10-19years and caretakers of children below 18years.

methodsWe conducted a qualitative study from February 2022 to March 2023, at three paediatric and adolescent HIV treatment centers in Uganda. In-depth interviews were conducted at TPT initiation and after completion for purposively selected health workers, adolescents aged 10-19 years living with HIV, and caretakers of children aged below 18years.

resultsThe desire to avoid TB disease, previous TB treatment, encouragement from family members, and ministry of health policies emerged as key facilitators for the children and adolescents to initiate TPT. Barriers to TPT initiation included; TB and HIV-related stigma, busy carer and adolescent work schedules, reduced social support from parents and family, history of drug side effects, high pill burden and fatigue, and perception of not being ill. TPT completion was enabled by combined TPT and ART refill visits, delivery of ART and TPT within the community, and continuous education and counseling from health workers. Reported barriers to TPT completion included TB and HIV-related stigma, long waiting time. Non-disclosure of HIV status by caretakers to CALHIV and fear of side effects was cited by health workers as a barrier to starting TPT. Facilitators of TPT initiation and completion reported by healthcare workers included patient and caretaker health education, counselling about benefits of TPT and risk of TB disease, having same appointment for TPT and ART refill to reduce patient waiting time, adolescent-friendly services, and appointment reminder phone calls.

conclusionThe facilitators and barriers of TPT initiation and completion among CALHIV span from individual, to health system and structural factors. Health education about benefits of TPT and risk of TB, social support, adolescent-friendly services, and joint appointments for TPT and ART refill are major facilitators of TPT initiation and completion among CALHIV in Uganda.

Indexed as

CaregiversHealth PersonnelHIV InfectionsQualitative ResearchTuberculosisAdolescentAdultAntitubercular AgentsChildFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansMalePatient Acceptance of Health CareSocial StigmaAntitubercular AgentsAdolescentsBarriersCaretakersChildrenCompletionFacilitatorsHIVInitiationPreventive treatmentTuberculosis

Identifiers

PMID39210349
PMCPMC11363537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.